IPSC Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Century Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 3.04 USD 4.47%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast IPSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPSC is 15.13 USD with a low forecast of 9.09 USD and a high forecast of 25.2 USD.

IPSC Lowest Forecast

Wall Street Target

IPSC Average Forecast

Wall Street Target

IPSC Highest Forecast

Wall Street Target

199% Upside

398% Upside

729% Upside

The latest public price target was made on Apr 12, 2024 by Edward Tenthoff from Piper Sandler , who expects IPSC stock to rise by 196% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Edward Tenthoff Piper Sandler	9 USD Upside 196%	2 weeks ago Apr 12, 2024	Century Therapeutics (IPSC) PT Lowered to $9 at Piper Sandler StreetInsider

Price Target	9 USD
Upside/Downside	196%

ChemPartner PharmaTech Co Ltd

183% Upside

Lepu Biopharma Co Ltd

39% Downside

Deciphera Pharmaceuticals Inc

6% Upside

PYC Therapeutics Ltd

248% Upside

ChemPartner PharmaTech Co Ltd

183% Upside

Lepu Biopharma Co Ltd

39% Downside

Deciphera Pharmaceuticals Inc

6% Upside

PYC Therapeutics Ltd

248% Upside

2Seventy Bio Inc

144% Upside

Affimed NV

333% Upside

Shanghai MicuRx Pharmaceutical Co Ltd

71% Upside

Sinocelltech Group Ltd

62% Upside

Revenue
Forecast

The compound annual growth rate of Century Therapeutics Inc's revenue for the next 3 years is 91%.

N/A

91%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-8%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-15%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for IPSC is 15.13 USD with a low forecast of 9.09 USD and a high forecast of 25.2 USD.

The compound annual growth rate of Century Therapeutics Inc's revenue for the next 3 years is 91%.

Join more than 133,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.